Universal Health Services (UHS) has declared a
$0.20 quarterly dividend to be paid in December 2024. Major activities witnessed within the UHS group have seen the
Principal Financial Group Inc. selling off 5,655 shares of UHS, while a UHS director recently sold a notable $308,515 in stock. A potentially significant issue for UHS may be an
unexpected $535M negligence decision against its behavioral health subsidiary, appealing to which might be the near future plan. The company is prepared to announce the third quarter 2024 earnings soon. Meanwhile, controversial accusations related to former
staff falsifying patient records have emerged, and more than 100 former patients have filed significant lawsuits against UHS for alleged abuse. Goldman Sachs indicates the UHS to be a stock with a high consensus ROE. The appeal for UHS is shown in its exceptions as a non-tech stock with its long-term investment potential. As the company works colloquially with top-notch systems like Hippocratic AI with the backing of General Catalyst, a16z, Memorial Hermann, and other health systems. Subsequently, UHS founder
Alan B. Miller stepped down as CEO in January 2021 and continued as the executive chairman.
Universal Health Services Class B UHS News Analytics from Wed, 07 Dec 2016 08:00:00 GMT to Thu, 26 Dec 2024 08:00:00 GMT -
Rating -3
- Innovation 2
- Information 6
- Rumor -1
